Indications and uses
for prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness
for prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness
do not take more than directed dosage should be taken one hour before travel starts chew or crush tablets completely before swallowing; do not swallow tablets whole adults and children 12 years and over: take 1 to 2 chewable tablets once daily or as directed by a doctor
TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) protect from heat and humidity see end flap for expiration date and lot number
Meclizine HCl 25 mg
Antiemetic
for prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness
for children under 12 years of age unless directed by a doctor.
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
colloidal silicon dioxide, dextrose, FD&C red #40 aluminum lake, flavor, lactose monohydrate, magnesium stearate, pregelatinized starch, propylene glycol, saccharin sodium, silicon dioxide
1-800-426-9391
♥CVS™
NDC 51316-404-02
UP TO
24
HR
actual size
Raspberry
Flavor
MOTION SICKNESS RELIEF
Meclizine Hydrochloride, 25 mg Chewable Tablets, Antiemetic
Compare to Bonine® Chewable Tablets active ingredient*
Prevents Nausea, Vomiting & Dizziness
12 CHEWABLE TABLETS
Ages 12 Years
& Older
Chew or crush tablets
completely before swallowing.
Do not swallow tablets whole.
TAMPER EVIDENT: DO NOT USE IF PACKAGE IS
OPENED OR IF BLISTER UNIT IS TORN, BROKEN
OR SHOWS ANY SIGNS OF TAMPERING
*This product is not manufactured
or distributed by WellSpring
Pharmaceutical Corporation,
owner of the registered
trademark Bonine®
Chewable Tablets.
Distributed by: CVS Pharmacy, Inc.
One CVS Drive, Woonsocket, RI 02895
© 2026 CVS/pharmacy CVS.com®
1-800-SHOP CVS V-14236
100% money back
guaranteed.
CVS.com/returnpolicy
50844 ORG082340402

| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51316-404-02 | Motion Sickness Relief | 2 in 1 CARTON | TABLET, CHEWABLE | 2 | 4 | |
| 51316-404-02 | Motion Sickness Relief | 6 in 1 BLISTER PACK | TABLET, CHEWABLE | 6 | 4 | |
| 51316-404-21 | Motion Sickness Relief | 8 in 1 BLISTER PACK | TABLET, CHEWABLE | 8 | 4 | |
| 51316-404-21 | Motion Sickness Relief | 2 in 1 CARTON | TABLET, CHEWABLE | 2 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51316-404 | 51316-404-02, 51316-404-21 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MECLIZINE HYDROCHLORIDE | 008PUV3986 | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| DEXTROSE, UNSPECIFIED FORM | IY9XDZ35W2 | IACT |
| FD&C RED NO. 40 ALUMINUM LAKE | 6T47AS764T | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Motion Sickness Relief | MECLIZINE HCL | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 4f806804-48c7-414e-a177-5d3daf5b22e3 | 2026-01-20 | Warnings | 51316-404-21 51316-404-02 51316-404 51316040402 51316040421 56b1ee38-4afb-4201-b205-9f1edd1aceeb 4f806804-48c7-414e-a177-5d3daf5b22e3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.